…fazimine, bedaquiline and the fluoroquinolones (levofloxacin or moxifloxacin). PK sampling will be divided as follows: 30 individuals will u…
Browse by entity family
An entity family is a category of extracted information. Choose one to browse its named entities and supporting articles.
Organisations named as supporting, sponsoring, or funding research.
5,089 articles · 9,137 mentionsInstitutionsUniversities, hospitals, research centres, networks, and public bodies.
11,350 articles · 22,378 mentionsDrugsNamed medicines, compounds, vaccines, and pharmacological agents.
10,506 articles · 58,393 mentionsDiseasesNamed diseases, disorders, syndromes, injuries, and health conditions.
23,712 articles · 125,551 mentionsTreatmentsClinical therapies and care approaches used to manage a condition.
7,227 articles · 16,644 mentionsInterventionsProgrammes, procedures, policies, and other actions being evaluated.
4,132 articles · 9,994 mentionsClinical instrumentsNamed questionnaires, scales, scores, indices, and other clinical outcome assessments.
945 articles · 1,957 mentionsPopular entities in these results
Choose an entity to see the articles in which it was identified.
Matching articles
29,499 articles · page 233 of 2459…Diarrhoea remains a major problem among children in low- and middle-incom…
…atients were stratified by autoimmune burden: Group 1 (isolated SLE), Group 2 (SLE + 1 AD), and Group 3 (SLE + 2 or more ADs). Auto…
…ease (MCTD), undifferentiated connective tissue disease (UCTD), rheumatoid arthritis (RA), primary anti-phospholipid syndrome (PAPS)), and 22 health…
…for refractory thrombocytopenia.Conclusions Thrombocytopenia in SLE remains relatively common. Its reported association with severe…
…d APS, refractory to glucocorticoids, successfully treated with ravulizumab, a terminal complement inhibitor.Methods A 30-year-old woman wi…
…nosed with SLE, while one patient developed uveitis while under azathioprine treatment. Therapeutic management included local corticosteroid…
…t genes associated with gut homing (e.g. CCR9) were enriched in SLE IgA2+ B cells.Abstract PO:06:166 Figure 1Figure 1. B cell reper…
…26]), with median FACIT-Fatigue 32 (18–43). Corticosteroids and hydroxychloroquine were most frequently used (85.5% and 81.7%), followed by azathi…
…levated proteinuria, kidney biopsy was performed and revealed a lupus nephritis class III with focal glomerulonephritis, and a modified NIH act…
…Objectives Lupus nephritis (LN) remains a major determinant of morbidity and mortality in …